| About the author: |
O. M. Bilovol, I. I. Kniazkova, V. M. Mishchenko, A. V Zhadan, N. V. Kuzminova, A. V. Starenky, M. V. Bogun |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The purpose of the study was to conduct a comparative analysis of the effect of 3-month therapy with a fixed combination of lisinopril dihydrate and amlodipine besylate on the clinical status, indicators of the daily profile of blood pressure, central aortic pressure and vascular stiffness, as well as the structural and functional state of the heart in patients with arterial hypertension with obesity and without it. 60 patients (average age 56.7±2.1 years) with stage 2 arterial hypertension were examined, 34 of which were diagnosed with Class 1 obesity (group 1) and 26 patients (group 2) without obesity who did not take regular antihypertensive therapy. After registration of baseline data, a fixed combination of lisinopril dihydrate and amlodipine besylate 10–20/5–10 mg/day was prescribed to the patients of both groups for 3 months. The control group consisted of 20 practically healthy people. After therapy, a significant improvement was found not only in the office systolic and diastolic blood pressure levels, but also in the daily profile of peripheral blood pressure and central blood pressure in both groups of patients. It was also established that the pulse wave propagation speed decreased by (1.0±0.2 m/s; p<0.01) in group 1 and by (1.5±0.2 m/s; p<0.01) in group 2. A significant decrease in the left ventricular myocardial mass index was found in both groups of patients. An increase in the E/A ratio was established by 33.3 % (p<0.001) in group 1 and by 26.3 % (p<0.01) in the patients of group 2. Thus, the long-term use of a fixed combination of lisinopril dihydrate and amlodipine besylate in arterial hypertension patients with obesity and without it, allows to control blood pressure effectively according to office measurement and daily blood pressure monitoring, has a positive effect on daily blood pressure profiles and indicators of arterial stiffness, as well as structural and functional parameters and status of diastolic function of the left ventricle, along with good tolerability of therapy. |
| Tags |
hypertension,obesity,central aortic pressure,elastic properties of arteries,echocardiography,fixed combination of lisinopril dihydrate and amlodipine besylate |
| Bibliography |
- Zhdan VM, Kitura YeM, Kitura OYe, Babanina MYu, Tkachenko MV. Klinichni pidkhody do terapiyi arterialnoyi hipertenziyi u zhinok u period postmenopauzy. Simeyna medytsyna. 2019; 2 (82) :76–79. [in Ukrainian]
- Katerenchuk IP, Mokhnachov OV. Komplaiens yak peredumova efektyvnosti terapiyi komorbidnoho perebihu hipertonichnoyi khvoroby. Visnyk problem biolohiyi i medytsyny. 2019; 2(2) :120–123. [in Ukrainian]
- Al-Makki A, DiPette D, Whelton PK, et al. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension.2022;79(1):293–301. doi: 10.1161/HYPERTENSIONAHA.121.18192.
- Ashtary-Larky D, Niknam S, Alipour M, Bagheri R, Asbaghi O, Mohammadian M, Jaime SJ, Baker JS, Wong A, Suzuki K, Afrisham R. Are Women with Normal-Weight Obesity at Higher Risk for Cardiometabolic Disorders? Biomedicines. 2023; 11(2): 341. doi: 10.3390/biomedicines11020341.
- Chao H, Hu Yu, Wang Q, Tang B, Adji A, Avolio A, Qian K., Zuo J. Impact of Obesity Phenotype on Central Aortic Hemodynamics and Arterial Stiffness in a Chinese Health Assessment Population. Rev. Cardiovasc. Med. 2022; 23(6): 216. https://doi.org/10.31083/j.rcm2306216
- Cheng Y-B, Xia J-H, Li Y, Wang J-G. Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials. Front. Physiol. 2021; 12: 762586. doi: 10.3389/fphys.2021.762586
- El Meouchy P, Wahoud M, Allam S, Chedid R, Karam W, Karam S. Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control. Int J Mol Sci. 2022; 23(20): 12305. doi: 10.3390/ijms232012305.
- ESC/ESH Guidelines for the management of arterial hypertension. 2018. ESC Scientific Document Group. Eur Heart J. 2018; 39(33):.3021–3104. doi: 10.1093/eurheartj/ehy339.
- Fahed G, Aoun L, Zerdan BM, Allam S, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022;23:786. doi: 10.3390/ijms23020786.
- Kapustnick YuA, Lutsenko RV, Sуdorenko AH. Combined pharmacological therapy including several antiarrhythmic agents for treatment of different disorders of cardiac rhythm. GeorGian Medical news. 2021; 6 (315): 85–93.
- Moselakgomo KV, van Staden M. Diagnostic comparison of Centers for Disease Control and Prevention and International Obesity Task Force criteria for obesity classification in South African children. Afr. J. Prim. Health Care Fam. Med. 2017;9: e1–e7. doi: 10.4102/phcfm. v9i1.1383
- Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, et al. Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat. Rev. Endocrinol. 2020; 16:177–189. doi: 10.1038/s41574-019-0310-7.
- Sood MR, Abdelmoneim SS, Dontineni N, Ivanov A, Lee E, Rubin M, Vittoria M, Meykler M, Ramachandran V, Sacchi T, Brener S, Klem I, Heitner JF. Descending Aortic Distensibility and Cardiovascular Outcomes: A Cardiac Magnetic Resonance Imaging Study. Vasc Health Risk Manag. 2022 Aug 30; 18:653–665. doi: 10.2147/VHRM.S359632.
- Xiong Y, Shi W, Huang X, Yu C, Zhou W, Bao H, Cheng X. Association between weight-adjusted waist index and arterial stiffness in hypertensive patients: The China H-type hypertension registry study. Front. Endocrinol. 2023; 14:1134065. doi: 10.3389/fendo.2023.1134065.
|
| Publication of the article |
«World of Medicine and Biology» №2(84), 2023 year, 040-045 pages, index UDK 616.12-008.331.1-056.257-085.225.2 |
| DOI |
10.26724/2079-8334-2023-2-84-40-45 |
